Founder and CEO of Reboot Rx, the nonprofit health tech startup dedicated to fast-tracking the development of affordable cancer treatments using repurposed generic drugs, AI technology, and innovative funding models. Passionate about collaborating across disciplines and sectors to expand treatment options for cancer patients. PhD in Computational and Systems Biology from MIT, American Cancer Society Postdoctoral Fellow at the Massachusetts General Hospital and Harvard Medical School, and most recently Scientific Research Director in the Department of Data Sciences at the Dana-Farber Cancer Institute. Featured in Forbes, the Boston Business Journal, Inside Philanthropy, and Life Science Leader, and received awards from 40 Under 40 in Cancer, the Massachusetts Life Sciences Center’s Massachusetts Next Generation Initiative, The Commonwealth Institute’s Extraordinary Women Advancing Healthcare, and the Dana-Farber Cancer Institute. Draper Richards Kaplan Foundation Entrepreneur and Henri Termeer Fellow.Reboot Rx has been recognized through awards from Fast Forward, Google.org, MassChallenge, The Greater Sum Foundation, Massachusetts Innovation Network, and MassBio. Reboot Rx was featured as a social impact startup to watch by BostInno. Learn more at www.rebootrx.org.
Listed skills include Cancer Research, Systems Biology, Cell Biology, Cell Culture, and 27 others.